Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Cancer Vaccines01:30

Cancer Vaccines

1.2K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Investigating a clinically actionable <i>BRAF</i> mutation for monitoring low-grade serous ovarian cancer: A case report.

Case reports in women's health·2022
Same author

Recent advances in immune-based approaches for the treatment of esophagogastric cancer.

Expert opinion on emerging drugs·2021
Same author

Modulation of tumor eIF4E by antisense inhibition: A phase I/II translational clinical trial of ISIS 183750-an antisense oligonucleotide against eIF4E-in combination with irinotecan in solid tumors and irinotecan-refractory colorectal cancer.

International journal of cancer·2016
Same author

A phase II study of TRC105 in patients with hepatocellular carcinoma who have progressed on sorafenib.

United European gastroenterology journal·2015
Same author

[Diagnosis of and therapy for hepatocellular carcinoma].

Zeitschrift fur Gastroenterologie·2013
Same author

Immunological off-target effects of standard treatments in gastrointestinal cancers.

Annals of oncology : official journal of the European Society for Medical Oncology·2013

Related Experiment Video

Updated: Mar 3, 2026

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
06:38

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

9.6K

Treating Hepatobiliary Cancer: The Immunologic Approach.

A G Duffy1, T F Greten

  • 1Gastrointestinal Malignancies Section, Thoracic-GI Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Digestive Diseases (Basel, Switzerland)
|May 4, 2017
PubMed
Summary
This summary is machine-generated.

Hepatobiliary cancers have limited treatment options. This review explores immune-based therapies, leveraging the inflammation link, for better cancer management.

Keywords:
CholangiocarcinomaHepatobiliaryImmuneImmune-evasionInflammation

More Related Videos

Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma
08:25

Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma

Published on: April 25, 2025

868
Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment &#8212; Challenges and Innovations in Cancer Prognosis
07:32

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Published on: April 12, 2024

2.1K

Related Experiment Videos

Last Updated: Mar 3, 2026

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
06:38

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

9.6K
Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma
08:25

Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma

Published on: April 25, 2025

868
Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment &#8212; Challenges and Innovations in Cancer Prognosis
07:32

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Published on: April 12, 2024

2.1K

Area of Science:

  • Oncology
  • Immunology
  • Hepatology

Background:

  • Hepatobiliary cancers are a diverse group with slow-evolving, minimally effective standard treatments for advanced stages.
  • Similar to many gastrointestinal cancers, the potential of immune-based therapies remains largely unexplored.
  • The strong association between hepatobiliary cancer etiology and inflammation suggests a promising avenue for immune-based interventions.

Purpose of the Study:

  • To contextualize hepatobiliary cancer management within its inflammation-based etiology.
  • To identify and highlight therapeutic opportunities in emerging immune-based approaches for hepatobiliary cancers.

Main Methods:

  • Literature review focusing on the etiological links between inflammation and hepatobiliary cancer.
  • Analysis of current and upcoming immune-based therapeutic strategies relevant to these malignancies.

Main Results:

  • The inflammation-rich background of hepatobiliary cancers provides a rationale for immune-based treatments.
  • Several immune-based approaches are entering clinical practice and show potential for this patient group.

Conclusions:

  • Immune-based therapies represent a significant, largely untapped therapeutic frontier for hepatobiliary cancers.
  • Understanding the inflammatory underpinnings is key to unlocking the potential of immunotherapy in managing these diseases.